Castlight Health, Inc. CSLT
Set alert
2.05 0.00 0.00%
As of Apr 24, 3:47 PM ET
2.04 Day range 2.05
52-week range unavailable
- Open
- 2.04
- Prev close
- 2.05
- Mkt cap
- 0
- Vol
- 0
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 2.04
- High
- 2.05
- Forward P/E
- -205.00
- Beta
- 1.66
- Short ratio
- 0.39
- Inst. own
- 74.44%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Jan 3, 2023
- 50-d avg
- 1.85
- 200-d avg
- 1.88
- 1y target
- 2.05
Analyst view
Consensus: hold
Hold
Price target (mean) 2.05
Ratings (0m) 11 5 buy · 5 hold · 1 sell
- Strong buy4
- Buy1
- Hold5
- Sell1
- Strong sell0
Recommendation trend
- This month 11
- 1 month ago 2
- 2 months ago 2
- 3 months ago 5
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.03 | -0.03 – -0.03 | 0.02 | -250.0% | 34.64M | -6.6% | 1 |
| Next quarter | 0.00 | 0.00 – 0.00 | 0.01 | -100.0% | 36.10M | +3.0% | 1 |
| Current year | 0.00 | 0.00 – 0.00 | 0.05 | -100.0% | 140.08M | -4.5% | 1 |
| Next year | -0.01 | -0.01 – -0.01 | 0.00 | 0.0% | 144.16M | +2.9% | 1 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Feb 11, 2021 | Canaccord Genuity | Maintained | — | Hold |
| May 19, 2020 | Wells Fargo | Maintained | — | Underweight |
| Feb 26, 2020 | Cantor Fitzgerald | Reiterated | — | Neutral |
| Jan 8, 2020 | Wells Fargo | Downgrade | Equal-Weight | Underweight |
| Nov 20, 2019 | Canaccord Genuity | Downgrade | Buy | Hold |
| Jul 31, 2019 | Cantor Fitzgerald | Downgrade | Overweight | Neutral |
| Jul 31, 2018 | Canaccord Genuity | Maintained | Buy | Buy |
| Jul 31, 2018 | Chardan Capital | Downgrade | Buy | Hold |
| Jun 20, 2018 | William Blair | Initiated | — | Outperform |
| Jan 31, 2018 | Cantor Fitzgerald | Upgrade | Neutral | Overweight |
| Oct 10, 2017 | Canaccord Genuity | Upgrade | Hold | Buy |
| Jun 6, 2017 | Chardan Capital | Initiated | — | Buy |
| May 12, 2017 | Morgan Stanley | Downgrade | Equal-Weight | Underweight |
| May 10, 2017 | Dougherty | Initiated | — | Buy |
| Jan 30, 2017 | Cowen & Co. | Initiated | — | Market Perform |
| Jan 6, 2017 | Cantor Fitzgerald | Initiated | — | Neutral |
| Jan 5, 2017 | Raymond James | Downgrade | Outperform | Market Perform |
| Feb 18, 2016 | Stifel Nicolaus | Maintained | — | Buy |
| Dec 16, 2015 | Topeka | Initiated | — | Buy |
| Nov 18, 2015 | FBR Capital | Initiated | — | Market Perform |
| Nov 5, 2015 | Stifel Nicolaus | Maintained | — | Buy |
| Nov 5, 2015 | Leerink Swann | Downgrade | Outperform | Market Perform |
| Jun 17, 2015 | Canaccord Genuity | Maintained | — | Hold |
| Jun 15, 2015 | Raymond James | Maintained | — | Outperform |
| May 7, 2015 | Canaccord Genuity | Maintained | — | Hold |
| Mar 20, 2015 | Wells Fargo | Initiated | — | Market Perform |
| Feb 19, 2015 | Stifel Nicolaus | Maintained | — | Buy |
| Dec 4, 2014 | First Analysis | Initiated | — | Equal-Weight |
| Oct 27, 2014 | Leerink Swann | Initiated | — | Outperform |
| Jul 29, 2014 | Raymond James | Maintained | — | Outperform |